Drugs / NBX-100
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07399899 | Jan → Mar 2026 overdue | — | Neurala Biosciences | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NBX-100 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07399899 ↗ |
| Route | Oral | “NBX-100 oral capsules” NCT07399899 ↗ |